157 related articles for article (PubMed ID: 38480774)
21. Correlation between IFNAR1 expression in peripheral blood T lymphocytes and inflammatory cytokines, tumor-infiltrating lymphocytes, and chemosensitivity in patients with colorectal cancer.
Yang L; Zhang X; Huang X; Dong X; Jing S; Zhang Y; Zhao B; Wang Z; Qu H
Cytokine; 2022 Nov; 159():156008. PubMed ID: 36063748
[TBL] [Abstract][Full Text] [Related]
22. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
[TBL] [Abstract][Full Text] [Related]
23. CXCL8 induces M2 macrophage polarization and inhibits CD8
Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
[TBL] [Abstract][Full Text] [Related]
24. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.
Yang Z; Gao A; Shi W; Wang J; Zhang X; Xu Z; Xu T; Zheng Y; Sun Y; Yang F
Onco Targets Ther; 2021; 14():4239-4254. PubMed ID: 34321889
[TBL] [Abstract][Full Text] [Related]
25. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
[TBL] [Abstract][Full Text] [Related]
26. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors.
Knopf P; Stowbur D; Hoffmann SHL; Hermann N; Maurer A; Bucher V; Poxleitner M; Tako B; Sonanini D; Krishnamachary B; Sinharay S; Fehrenbacher B; Gonzalez-Menendez I; Reckmann F; Bomze D; Flatz L; Kramer D; Schaller M; Forchhammer S; Bhujwalla ZM; Quintanilla-Martinez L; Schulze-Osthoff K; Pagel MD; Fransen MF; Röcken M; Martins AF; Pichler BJ; Ghoreschi K; Kneilling M
Mol Cancer; 2023 Dec; 22(1):207. PubMed ID: 38102680
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
28. [Calnexin (CNX) enhances the killing effect of CD8
Yang T; Zheng J; Gao S; Cheng M; Xue Y; Shao Y; Li Y; Yang T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):97-102. PubMed ID: 35356876
[TBL] [Abstract][Full Text] [Related]
29. BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8
Li W; Zhao C; Li W; Gong Y; Ma K; Lu Y; Liu X; Zhang L; Guo F
J Transl Med; 2023 Oct; 21(1):737. PubMed ID: 37853469
[TBL] [Abstract][Full Text] [Related]
30. IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8
Shen W; Wang X; Xiang H; Shichi S; Nakamoto H; Kimura S; Sugiyama K; Taketomi A; Kitamura H
Cancer Sci; 2023 May; 114(5):1816-1829. PubMed ID: 36715504
[TBL] [Abstract][Full Text] [Related]
31. Follicular helper T cells promote the effector functions of CD8
Shi W; Dong L; Sun Q; Ding H; Meng J; Dai G
Exp Cell Res; 2018 Nov; 372(1):35-42. PubMed ID: 30205088
[TBL] [Abstract][Full Text] [Related]
32. Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment.
Lin W; Luo Y; Wu J; Zhang H; Jin G; Guo C; Zhou H; Liang H; Xu X
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37935565
[TBL] [Abstract][Full Text] [Related]
33. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
34. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
Lv Y; Tang W; Xu Y; Chang W; Zhang Z; Lin Q; Ji M; Feng Q; He G; Xu J
Int J Biol Sci; 2023; 19(4):1284-1298. PubMed ID: 36923931
[No Abstract] [Full Text] [Related]
36. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
Fitzpatrick L; Makrigiannis AP; Kaiser M; Hoskin DW
J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
[TBL] [Abstract][Full Text] [Related]
37. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
Kato Y; Tabata K; Kimura T; Yachie-Kinoshita A; Ozawa Y; Yamada K; Ito J; Tachino S; Hori Y; Matsuki M; Matsuoka Y; Ghosh S; Kitano H; Nomoto K; Matsui J; Funahashi Y
PLoS One; 2019; 14(2):e0212513. PubMed ID: 30811474
[TBL] [Abstract][Full Text] [Related]
38. Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study.
Radice E; Miranda V; Bellone G
Int Immunopharmacol; 2014 Mar; 19(1):66-73. PubMed ID: 24369312
[TBL] [Abstract][Full Text] [Related]
39. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.
Sui Q; Liu D; Jiang W; Tang J; Kong L; Han K; Liao L; Li Y; Ou Q; Xiao B; Liu G; Ling Y; Chen J; Liu Z; Zuo Z; Pan Z; Zhou P; Zheng J; Ding PR
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33782107
[TBL] [Abstract][Full Text] [Related]
40. N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy.
Krug J; Rodrian G; Petter K; Yang H; Khoziainova S; Guo W; Bénard A; Merkel S; Gellert S; Maschauer S; Spermann M; Waldner M; Bailey P; Pilarsky C; Liebl A; Tripal P; Christoph J; Naschberger E; Croner R; Schellerer VS; Becker C; Hartmann A; Tüting T; Prante O; Grützmann R; Grivennikov SI; Stürzl M; Britzen-Laurent N
Gastroenterology; 2023 Mar; 164(3):392-406.e5. PubMed ID: 36402190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]